HeartBeam Launches Next-Gen ECG System to Address 919,000 Annual U.S. Cardiac Deaths
HeartBeam is rolling out its HeartBeam System, a next-generation ECG platform designed to reduce patient delays and enhance early detection of cardiac conditions. The solution targets gaps in monitoring as U.S. cardiovascular disease claimed 919,000 lives in 2023.
1. Cardiac Disease Challenge
Cardiovascular disease remains the leading cause of death in the U.S., accounting for 919,000 fatalities in 2023. Aging populations, lifestyle factors and patient hesitancy to seek care contribute to persistent gaps in early detection, underscoring urgent demand for improved diagnostic tools.
2. HeartBeam System Development
HeartBeam is advancing its HeartBeam System to transform how ECG data are collected and analyzed, aiming to accelerate diagnosis and reduce delays in treatment. The next-generation platform integrates novel sensor technology and data analytics to enhance monitoring and support clinical decision-making.